pharmaceuticals-and-healthcare

Global DTaP and Tdap Vaccines Sales Market Report 2018


Published On : Aug 2018

Category : Pharmaceutical

No. of Pages : 111 pages

  • $4000
  • $8000

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global DTaP and Tdap Vaccines market status and forecast, categorizes the global DTaP and Tdap Vaccines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEFs total procurement.

Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.

The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.
The global DTaP and Tdap Vaccines market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
DTaP
Td
Tdap
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Adult
Pediatric

The study objectives of this report are:
To analyze and study the global DTaP and Tdap Vaccines sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key DTaP and Tdap Vaccines players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of DTaP and Tdap Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
DTaP and Tdap Vaccines Manufacturers
DTaP and Tdap Vaccines Distributors/Traders/Wholesalers
DTaP and Tdap Vaccines Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the DTaP and Tdap Vaccines market, by end-use.
Detailed analysis and profiles of additional market players.

In the recent times, the global market for Global dtap and tdap vaccines sales market report 2018 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global dtap and tdap vaccines sales market report 2018 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global dtap and tdap vaccines sales market report 2018 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global dtap and tdap vaccines sales market report 2018 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global dtap and tdap vaccines sales market report 2018 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global dtap and tdap vaccines sales market report 2018, including the definition, classification, and industry chain structure of Global dtap and tdap vaccines sales market report 2018, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global dtap and tdap vaccines sales market report 2018.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global dtap and tdap vaccines sales market report 2018 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global dtap and tdap vaccines sales market report 2018, implemented in each of the geographical segments. The predominant applications of the Global dtap and tdap vaccines sales market report 2018 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global dtap and tdap vaccines sales market report 2018 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global dtap and tdap vaccines sales market report 2018 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of DTaP and Tdap Vaccines
Figure Global DTaP and Tdap Vaccines Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global DTaP and Tdap Vaccines Sales Volume Market Share by Type (Product Category) in 2017
Figure DTaP Product Picture
Figure Td Product Picture
Figure Tdap Product Picture
Figure Global DTaP and Tdap Vaccines Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of DTaP and Tdap Vaccines by Application in 2017
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure Pediatric Examples
Table Key Downstream Customer in Pediatric
Figure Global DTaP and Tdap Vaccines Market Size (Million USD) by Regions (2013-2025)
Figure United States DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure China DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure India DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global DTaP and Tdap Vaccines Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players DTaP and Tdap Vaccines Sales Volume (K Units) (2013-2018)
Table Global DTaP and Tdap Vaccines Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Share by Players/Suppliers (2013-2018)
Figure 2017 DTaP and Tdap Vaccines Sales Share by Players/Suppliers
Figure 2017 DTaP and Tdap Vaccines Sales Share by Players/Suppliers
Figure Global DTaP and Tdap Vaccines Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global DTaP and Tdap Vaccines Revenue Share by Players
Table 2017 Global DTaP and Tdap Vaccines Revenue Share by Players
Table Global DTaP and Tdap Vaccines Sales (K Units) and Market Share by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of DTaP and Tdap Vaccines by Type (2013-2018)
Figure Global DTaP and Tdap Vaccines Sales Growth Rate by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Figure Revenue Market Share of DTaP and Tdap Vaccines by Type (2013-2018)
Figure Global DTaP and Tdap Vaccines Revenue Growth Rate by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Share by Region (2013-2018)
Figure Sales Market Share of DTaP and Tdap Vaccines by Region (2013-2018)
Figure Global DTaP and Tdap Vaccines Sales Growth Rate by Region in 2017
Table Global DTaP and Tdap Vaccines Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of DTaP and Tdap Vaccines by Region (2013-2018)
Figure Global DTaP and Tdap Vaccines Revenue Growth Rate by Region in 2017
Table Global DTaP and Tdap Vaccines Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of DTaP and Tdap Vaccines by Region (2013-2018)
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Region in 2017
Table Global DTaP and Tdap Vaccines Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of DTaP and Tdap Vaccines by Application (2013-2018)
Figure Global DTaP and Tdap Vaccines Sales Market Share by Application (2013-2018)
Figure United States DTaP and Tdap Vaccines Sales (K Units) and Growth Rate (2013-2018)
Figure United States DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States DTaP and Tdap Vaccines Sales Price (USD/Unit) Trend (2013-2018)
Table United States DTaP and Tdap Vaccines Sales Volume (K Units) by Players (2013-2018)
Table United States DTaP and Tdap Vaccines Sales Volume Market Share by Players (2013-2018)
Figure United States DTaP and Tdap Vaccines Sales Volume Market Share by Players in 2017
Table United States DTaP and Tdap Vaccines Sales Volume (K Units) by Type (2013-2018)
Table United States DTaP and Tdap Vaccines Sales Volume Market Share by Type (2013-2018)
Figure United States DTaP and Tdap Vaccines Sales Volume Market Share by Type in 2017
Table United States DTaP and Tdap Vaccines Sales Volume (K Units) by Application (2013-2018)
Table United States DTaP and Tdap Vaccines Sales Volume Market Share by Application (2013-2018)
Figure United States DTaP and Tdap Vaccines Sales Volume Market Share by Application in 2017
Figure Europe DTaP and Tdap Vaccines Sales (K Units) and Growth Rate (2013-2018)
Figure Europe DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe DTaP and Tdap Vaccines Sales Price (USD/Unit) Trend (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Volume (K Units) by Players (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Volume Market Share by Players (2013-2018)
Figure Europe DTaP and Tdap Vaccines Sales Volume Market Share by Players in 2017
Table Europe DTaP and Tdap Vaccines Sales Volume (K Units) by Type (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Volume Market Share by Type (2013-2018)
Figure Europe DTaP and Tdap Vaccines Sales Volume Market Share by Type in 2017
Table Europe DTaP and Tdap Vaccines Sales Volume (K Units) by Application (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Volume Market Share by Application (2013-2018)
Figure Europe DTaP and Tdap Vaccines Sales Volume Market Share by Application in 2017
Figure China DTaP and Tdap Vaccines Sales (K Units) and Growth Rate (2013-2018)
Figure China DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2018)
Figure China DTaP and Tdap Vaccines Sales Price (USD/Unit) Trend (2013-2018)
Table China DTaP and Tdap Vaccines Sales Volume (K Units) by Players (2013-2018)
Table China DTaP and Tdap Vaccines Sales Volume Market Share by Players (2013-2018)
Figure China DTaP and Tdap Vaccines Sales Volume Market Share by Players in 2017
Table China DTaP and Tdap Vaccines Sales Volume (K Units) by Type (2013-2018)
Table China DTaP and Tdap Vaccines Sales Volume Market Share by Type (2013-2018)
Figure China DTaP and Tdap Vaccines Sales Volume Market Share by Type in 2017
Table China DTaP and Tdap Vaccines Sales Volume (K Units) by Application (2013-2018)
Table China DTaP and Tdap Vaccines Sales Volume Market Share by Application (2013-2018)
Figure China DTaP and Tdap Vaccines Sales Volume Market Share by Application in 2017
Figure Japan DTaP and Tdap Vaccines Sales (K Units) and Growth Rate (2013-2018)
Figure Japan DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan DTaP and Tdap Vaccines Sales Price (USD/Unit) Trend (2013-2018)
Table Japan DTaP and Tdap Vaccines Sales Volume (K Units) by Players (2013-2018)
Table Japan DTaP and Tdap Vaccines Sales Volume Market Share by Players (2013-2018)
Figure Japan DTaP and Tdap Vaccines Sales Volume Market Share by Players in 2017
Table Japan DTaP and Tdap Vaccines Sales Volume (K Units) by Type (2013-2018)
Table Japan DTaP and Tdap Vaccines Sales Volume Market Share by Type (2013-2018)
Figure Japan DTaP and Tdap Vaccines Sales Volume Market Share by Type in 2017
Table Japan DTaP and Tdap Vaccines Sales Volume (K Units) by Application (2013-2018)
Table Japan DTaP and Tdap Vaccines Sales Volume Market Share by Application (2013-2018)
Figure Japan DTaP and Tdap Vaccines Sales Volume Market Share by Application in 2017
Figure Southeast Asia DTaP and Tdap Vaccines Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia DTaP and Tdap Vaccines Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia DTaP and Tdap Vaccines Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia DTaP and Tdap Vaccines Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia DTaP and Tdap Vaccines Sales Volume Market Share by Players in 2017
Table Southeast Asia DTaP and Tdap Vaccines Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia DTaP and Tdap Vaccines Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia DTaP and Tdap Vaccines Sales Volume Market Share by Type in 2017
Table Southeast Asia DTaP and Tdap Vaccines Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia DTaP and Tdap Vaccines Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia DTaP and Tdap Vaccines Sales Volume Market Share by Application in 2017
Figure India DTaP and Tdap Vaccines Sales (K Units) and Growth Rate (2013-2018)
Figure India DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate (2013-2018)
Figure India DTaP and Tdap Vaccines Sales Price (USD/Unit) Trend (2013-2018)
Table India DTaP and Tdap Vaccines Sales Volume (K Units) by Players (2013-2018)
Table India DTaP and Tdap Vaccines Sales Volume Market Share by Players (2013-2018)
Figure India DTaP and Tdap Vaccines Sales Volume Market Share by Players in 2017
Table India DTaP and Tdap Vaccines Sales Volume (K Units) by Type (2013-2018)
Table India DTaP and Tdap Vaccines Sales Volume Market Share by Type (2013-2018)
Figure India DTaP and Tdap Vaccines Sales Volume Market Share by Type in 2017
Table India DTaP and Tdap Vaccines Sales Volume (K Units) by Application (2013-2018)
Table India DTaP and Tdap Vaccines Sales Volume Market Share by Application (2013-2018)
Figure India DTaP and Tdap Vaccines Sales Volume Market Share by Application in 2017
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Pasteur DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure Sanofi Pasteur DTaP and Tdap Vaccines Sales Global Market Share (2013-2018)
Figure Sanofi Pasteur DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline DTaP and Tdap Vaccines Sales Global Market Share (2013-2018)
Figure GlaxoSmithKline DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table Protein Sciences Corporation Basic Information List
Table Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Protein Sciences Corporation DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure Protein Sciences Corporation DTaP and Tdap Vaccines Sales Global Market Share (2013-2018
Figure Protein Sciences Corporation DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure Novartis AG DTaP and Tdap Vaccines Sales Global Market Share (2013-2018)
Figure Novartis AG DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table Seqirus Basic Information List
Table Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Seqirus DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure Seqirus DTaP and Tdap Vaccines Sales Global Market Share (2013-2018)
Figure Seqirus DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table Merck Sharp & Dohme Corp Basic Information List
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales Global Market Share (2013-2018
Figure Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table Astellas Pharma US, Inc Basic Information List
Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales Global Market Share (2013-2018)
Figure Astellas Pharma US, Inc DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table Pfizer Inc Basic Information List
Table Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Inc DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure Pfizer Inc DTaP and Tdap Vaccines Sales Global Market Share (2013-2018
Figure Pfizer Inc DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure Johnson & Johnson DTaP and Tdap Vaccines Sales Global Market Share (2013-2018)
Figure Johnson & Johnson DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table Lanzhou Institute of Biological Products Co., Ltd Basic Information List
Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales Growth Rate (2013-2018)
Figure Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales Global Market Share (2013-2018)
Figure Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table Emergent BioSolutions Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of DTaP and Tdap Vaccines
Figure Manufacturing Process Analysis of DTaP and Tdap Vaccines
Figure DTaP and Tdap Vaccines Industrial Chain Analysis
Table Raw Materials Sources of DTaP and Tdap Vaccines Major Players in 2017
Table Major Buyers of DTaP and Tdap Vaccines
Table Distributors/Traders List
Figure Global DTaP and Tdap Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global DTaP and Tdap Vaccines Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global DTaP and Tdap Vaccines Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global DTaP and Tdap Vaccines Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global DTaP and Tdap Vaccines Sales Volume Market Share Forecast by Regions in 2025
Table Global DTaP and Tdap Vaccines Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Regions (2018-2025)
Figure Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Regions in 2025
Figure United States DTaP and Tdap Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe DTaP and Tdap Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe DTaP and Tdap Vaccines Revenue and Growth Rate Forecast (2018-2025)
Figure China DTaP and Tdap Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan DTaP and Tdap Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia DTaP and Tdap Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India DTaP and Tdap Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India DTaP and Tdap Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global DTaP and Tdap Vaccines Sales (K Units) Forecast by Type (2018-2025)
Figure Global DTaP and Tdap Vaccines Sales Volume Market Share Forecast by Type (2018-2025)
Table Global DTaP and Tdap Vaccines Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Type (2018-2025)
Table Global DTaP and Tdap Vaccines Price (USD/Unit) Forecast by Type (2018-2025)
Table Global DTaP and Tdap Vaccines Sales (K Units) Forecast by Application (2018-2025)
Figure Global DTaP and Tdap Vaccines Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top